Nasdaq
AVBP
ArriVent BioPharma, Inc.
- Health Care
- Listed 2024
- 1 day
- +1.3%
- 1 month
- −9.3%
- 1 year
- +62.4%
$31.01 · Mkt cap $1.44B
At the 6 Aug 2026 close
Nasdaq
ArriVent BioPharma, Inc.
$31.01 · Mkt cap $1.44B
At the 6 Aug 2026 close
ArriVent BioPharma, Inc. trades under the ticker AVBP on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2024. Its market capitalisation is $1.44B. The last closing price was $31.01, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +62.4%, and −9.3% over the past month. Returns are price returns and exclude dividends.
This page exists because AVBP is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.